PriceSensitive

Entourage’s (TSXV:ENTG) CBD-infused ‘functional gum’ joins emerging market

Cannabis, Consumer, Market News
TSXV:ENTG
27 March 2023 10:06 (EDT)

Source: Entourage Health Corp.

Entourage Health (ENTG) has expanded its medical portfolio with the launch of its new CBD chewing gum.

The gum is available to Starseed Medicinal patients on the company’s medical platform. This new CBD chewing gum formulated to provide a rapid onset of CBD with 20 mg per unit (200 mg per pack). Cannabis-infused gum is made using CBD isolate in partnership with NordicCan, a global leader in oral and intra-oral delivery systems. The sugar-free gum is naturally flavoured with eucalyptus-lemon-mint, providing a controlled release of cannabinoids conveniently and discreetly.

“Our commitment to developing innovative product formulations has led us to engage with industry partners as part of our ongoing commitment to meeting our patients’ changing and varied needs. Introducing CBD chewing gum allows us to improve the patient experience with a consistent pipeline of products,” George Scorsis, the company’s CEO and Executive Chair stated. “We are proud to welcome our newest member union to our full-service Starseed medical platform. Through our partnership with Union Benefits, we are eliminating barriers to members accessing medical cannabis as an alternative therapy, educating patients, and providing responsible treatment options.”

Source: Entourage Health Corp.

Starseed offers more than 45 products, including cannabis-infused soft chews, transdermal patches, balms, oils, capsules, vapes, and dried flower products. 

Entourage Health is a licence holder producing and distributing cannabis products for both the medical and adult-use markets. It owns and operates greenhouse, outdoor, and processing facility located in Strathroy as well as a fully licensed Aylmer processing facility, specializing in cannabis extraction. With the addition of Starseed Medicinal, a medical-centric brand, it has expanded its multi-channeled distribution. The company operates in one segment, the production and sale of cannabis in Canada.

Entourage Health Corp. (ENTG) opened trading at C$0.02 per share.

Related News